You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Serous epithelial ovarian cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Ovarian Epithelial, Low Grade Serous Adenocarcinoma of Ovary Trial in Brescia, Genova (Letrozole tablets, carboplatin

Recruiting
  • Carcinoma, Ovarian Epithelial
  • Low Grade Serous Adenocarcinoma of Ovary
  • Letrozole tablets
  • carboplatin AUC 5 and paclitaxel 175 mg/m2
  • Brescia, BS, Italy
  • +1 more
Oct 26, 2022

Platinum-resistant Ovarian Cancer Trial in China (IN10018 in combination with PLD)

Recruiting
  • Platinum-resistant Ovarian Cancer
  • IN10018 in combination with PLD
  • Anyang, China
  • +6 more
Sep 20, 2022

Early Detection of High Grade Serous Epithelial Ovarian Cancer

Active, not recruiting
  • Epithelial Ovarian Cancer
  • DNA Methylation
  • Dallas, Texas
    Baylor University Medical Center
Jan 31, 2022

High Grade Serous Carcinoma, Triple Negative Breast Cancer, Ovarian Cancer Trial (Olaparib tablet, Navitoclax)

Recruiting
  • High Grade Serous Carcinoma
  • +2 more
  • Toronto, Ontario, Canada
  • +2 more
Nov 28, 2022

High Grade Serous Ovarian Cancer (HGSOC) Trial (FAPI PET CT)

Not yet recruiting
  • High Grade Serous Ovarian Cancer (HGSOC)
  • FAPI PET CT
  • (no location specified)
Jul 20, 2023

Pancreatic Cancer, Serous Ovarian Cancer Trial in Philadelphia (VCN-01, huCART-meso Cells)

Recruiting
  • Pancreatic Cancer
  • Serous Ovarian Cancer
  • VCN-01
  • huCART-meso Cells
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Feb 17, 2022

New Prognostic Index for Neoadjuvant Chemotherapy Outcome in

Enrolling by invitation
  • Ovarian Cancer
  • +2 more
  • CRS scoring
  • Routine blood laboratory testing before treatment
  • Guangzhou, Guangdong, China
    The Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Nov 2, 2023

Low Grade Serous Ovarian Cancer Trial (avutometinib + defactinib, Investigator Choice of Treatment (ICT))

Not yet recruiting
  • Low Grade Serous Ovarian Cancer
  • avutometinib + defactinib
  • Investigator Choice of Treatment (ICT)
  • (no location specified)
Oct 2, 2023

Adult Patients With Platinum-sensitive, Relapsed, High Grade Serous Epithelial Ovarian Cancer Trial in Pierre-Bénite

Recruiting
  • Adult Patients With Platinum-sensitive, Relapsed, High Grade Serous Epithelial Ovarian Cancer
  • Pharmacokinetics, Dosage of Niraparib
  • Pierre-Bénite, France
    Hôpital Lyon sud, Institut de Cancérologie des Hospices Civils d
Apr 19, 2022

Ovarian Cancer, Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Toronto (Niraparib)

Not yet recruiting
  • Ovarian Cancer
  • +3 more
  • Toronto, Ontario, Canada
    Sunnybrook Research Institute
Jul 18, 2023

Serous Ovarian Cancer, Advanced Ovarian Cancer Trial (SC0191, Gemcitabine, Paclitaxel)

Not yet recruiting
  • Serous Ovarian Cancer
  • Advanced Ovarian Cancer
  • (no location specified)
Sep 20, 2023

Ovarian Cancer, High Grade Serous Adenocarcinoma of Ovary, High Grade Endometrioid Ovarian Cancer Trial in Guangzhou (Fluzoparib

Not yet recruiting
  • Ovarian Cancer
  • +4 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Cetntre
Sep 25, 2023

High Grade Serous Ovarian Cancer Trial in Montpellier (Blood sample and tissue sample)

Not yet recruiting
  • High Grade Serous Ovarian Cancer
  • Blood sample and tissue sample
  • Montpellier, France
    NOUGARET Stephanie
Oct 10, 2023

Ovarian Cancer, Relapsed Ovarian Cancer, Fallopian Tube Cancer Trial (Carboplatin)

Not yet recruiting
  • Ovarian Cancer
  • +6 more
  • (no location specified)
Oct 27, 2022

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester

Active, not recruiting
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +22 more
  • Laboratory Biomarker Analysis
  • Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
  • Rochester, Minnesota
    Mayo Clinic
Oct 7, 2022

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma

Recruiting
  • Fallopian Tube Endometrioid Adenocarcinoma
  • +17 more
  • Biopsy
  • +3 more
  • Augusta, Georgia
  • +4 more
Jan 25, 2023

Ovarian Tumor Epithelial, Ovarian Cancer, Fallopian Tube Tumors Trial in India (Oregovomab, Paclitaxel, Carboplatin)

Not yet recruiting
  • Ovarian Neoplasm Epithelial
  • +4 more
  • Oregovomab
  • +3 more
  • Visakhapatnam, Andhra Pradesh, India
  • +7 more
Dec 7, 2022

BRCA1 Mutation, BRCA2 Mutation, Ovarian Cancer Trial in Providence (Talazoparib Oral Capsule)

Active, not recruiting
  • BRCA1 Mutation
  • +4 more
  • Talazoparib Oral Capsule
  • Providence, Rhode Island
  • +1 more
Nov 30, 2022

Ovarian Cancer, Serous Ovarian Cancer Trial in Pittsburgh (Regorafenib, Fulvestrant)

Not yet recruiting
  • Ovarian Cancer
  • Serous Ovarian Cancer
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Cancer Institute
Apr 17, 2022

Gynecologic Cancer, Ovarian Cancer, High Grade Serous Carcinoma Trial in Ljubljana (Carboplatin)

Recruiting
  • Gynecologic Cancer
  • +3 more
  • Ljubljana, Slovenia
  • +1 more
Aug 6, 2022

Patients With Low Grade Ovarian or Peritoneal Tumors

Recruiting
  • Low Grade Ovarian Serous Adenocarcinoma
  • +5 more
  • Biospecimen Collection
  • Electronic Health Record Review
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Endometrioid Cancer, Mucinous Ovarian Cancer, High Grade Serous Ovarian Cancer Trial in Oklahoma City (VS-6766 + defactinib)

Not yet recruiting
  • Endometrioid Cancer
  • +3 more
  • VS-6766 + defactinib
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center
Aug 19, 2022

Ovarian Cancer Trial in Kelowna, Vancouver, Kingston (Durvalumab, BA3011, BA3021)

Recruiting
  • Ovarian Cancer
  • Kelowna, British Columbia, Canada
  • +4 more
Nov 14, 2022

CINSARC Genomic Signature as Predictor of Resectability of

Completed
  • Ovarian Adenocarcinoma
  • CINSARC signature
  • Toulouse, France
    Institut Claudius Regaud Institut Universitaire du cancer Toulou
Dec 22, 2022

Chromosomal Instability in Ovarian Cancer

Recruiting
  • Epithelial Ovarian Cancer
  • +7 more
  • Testing for chromosomal instability (CIN)
  • Beijing, Beijing, China
    Lei Li
Mar 26, 2022